MwanzoIPN • EPA
add
Ipsen SA
Bei iliyotangulia
€ 147.60
Bei za siku
€ 146.90 - € 154.70
Bei za mwaka
€ 87.95 - € 154.70
Thamani ya kampuni katika soko
12.16B EUR
Wastani wa hisa zilizouzwa
elfu 93.87
Uwiano wa bei na mapato
28.83
Mgao wa faida
-
Ubadilishanaji wa msingi
EPA
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (EUR) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 996.05M | 9.29% |
Matumizi ya uendeshaji wa biashara | 547.60M | 9.30% |
Mapato halisi | 54.75M | -3.86% |
Kiwango cha faida halisi | 5.50 | -12.00% |
Mapato kwa kila hisa | — | — |
EBITDA | — | — |
Asilimia ya kodi ya mapato | 28.80% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (EUR) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 1.53B | 124.60% |
Jumla ya mali | — | — |
Jumla ya dhima | — | — |
Jumla ya hisa | — | — |
hisa zilizosalia | 82.50M | — |
Uwiano wa bei na thamani | 2.81 | — |
Faida inayotokana na mali | 8.49% | — |
Faida inayotokana mtaji | 11.28% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (EUR) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 54.75M | -3.86% |
Pesa kutokana na shughuli | 305.85M | 36.08% |
Pesa kutokana na uwekezaji | -241.15M | -1.01% |
Pesa kutokana na ufadhili | -28.15M | -125.80% |
Mabadiliko halisi ya pesa taslimu | 39.35M | -62.54% |
Mtiririko huru wa pesa | 120.22M | 75.05% |
Kuhusu
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.
Ipsen, founded by Henri Beaufour in 1929, has approximately 5000 employees worldwide. Ipsen's medicines are registered in 88 countries with direct commercial presence in over 30 countries. Ipsen has 4 global R&D hubs and 3 pharmaceutical development centers around the world. Ipsen has been a family-owned business for the past 90 years and is publicly traded on the Euronext Paris as part of the SBF 120 index. The Beaufour family owns 57% of its shares and 73% of its voting rights, and two of its members, Anne Beaufour and Henri Beaufour, sit on its board of directors. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1929
Tovuti
Wafanyakazi
5,358
